Determining the acceptable level of physician compliance with a treat-to-target strategy in early rheumatoid arthritis

International Journal of Rheumatic Diseases

Volumn 20, Issue 5, 2017, Pages 576-583

  Wabe, Nasir ^a   Sorich, Michael J ^a,b   Wechalekar, Mihir D ^b,c   Cleland, Leslie G ^c   McWilliams, Leah ^c   Lee, Anita ^c,d   Spargo, Llewellyn ^c   Metcalf, Robert ^c   Hall, Cindy ^c   Proudman, Susanna M ^c,d   Wiese, Michael D ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

^c ROYAL ADELAIDE HOSPITAL   (Australia)

^d UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

cut off value; physician compliance; rheumatoid arthritis; ROC curve; treat to target

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; CYCLOSPORIN A; HYDROXYCHLOROQUINE; LEFLUNOMIDE; METHOTREXATE; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE; ANTIRHEUMATIC AGENT;

ADULT; AGED; AREA UNDER RECEIVER OPERATING CHARACTERISTIC; AREA UNDER THE CURVE; ARTICLE; CLINICAL DECISION MAKING; CLINICAL DISEASE ACTIVITY INDEX; COHORT ANALYSIS; CONTROLLED STUDY; DAS28; DISEASE ACTIVITY; DRUG DOSE INCREASE; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; LOW DISEASE ACTIVITY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; PROTOCOL COMPLIANCE; RECEIVER OPERATING CHARACTERISTIC; REMISSION; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; SIMPLIFIED DISEASE ACTIVITY INDEX; TREAT TO TARGET STRATEGY; TREATMENT DURATION; TREATMENT OUTCOME; CLASSIFICATION; CLINICAL PRACTICE; DISABILITY; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; STANDARDS; TIME FACTOR;

AGED; ANTIRHEUMATIC AGENTS; AREA UNDER CURVE; ARTHRITIS, RHEUMATOID; DISABILITY EVALUATION; FEMALE; GUIDELINE ADHERENCE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PRACTICE PATTERNS, PHYSICIANS'; REMISSION INDUCTION; ROC CURVE; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 84952682825     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/1756-185X.12816     Document Type: Article

References (17)

1. Smolen JS, Aletaha D, Bijlsma JW et al. (2010) Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 69, 631–7.
2. Singh JA, Furst DE, Bharat A et al. (2012) 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) 64, 625–39.
3. Anderson J, Caplan L, Yazdany J et al. (2012) Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice. Arthritis Care Res (Hoboken) 64, 640–7.
4. Tymms K, Zochling J, Scott J et al. (2014) Barriers to optimal disease control for rheumatoid arthritis patients with moderate and high disease activity. Arthritis Care Res (Hoboken) 66, 190–6.
5. Vermeer M, Kuper HH, Bernelot Moens HJ et al. (2012) Adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the DREAM remission induction cohort. Arthritis Res Ther 14, R254.
6. Wolfe F, Michaud K (2007) Resistance of rheumatoid arthritis patients to changing therapy: discordance between disease activity and patients’ treatment choices. Arthritis Rheum 56, 2135–42.
7. Scott DL, Wolfe F, Huizinga TWJ (2010) Rheumatoid arthritis. Lancet 376, 1094–108.
8. Proudman SM, Keen HI, Stamp LK et al. (2007) Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use. Semin Arthritis Rheum 37, 99–111.
9. Wabe N, Sorich M, Wechalekar M et al. (2015) Characterising deviation from treat-to-target strategies for early rheumatoid arthritis: the first three years. Arthritis Res Ther 17 (1), 48.
10. Kumar R, Indrayan A (2011) Receiver operating characteristic (ROC) curve for medical researchers. Indian Pediatr 48, 277–87.
11. Perkins NJ, Schisterman EF (2006) The inconsistency of “optimal” cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol 163, 670–5.
12. Akobeng AK (2007) Understanding diagnostic tests 1: sensitivity, specificity and predictive values. Acta Paediatr 96, 338–41.
13. Šimundić A-M (2008) Measures of diagnostic accuracy: basic definitions. Med Biol Sci 22, 61–5.
14. Glas AS, Lijmer JG, Prins MH et al. (2003) The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 56, 1129–35.
15. Raslich MA, Markert RJ, Stutes SA (2007) Selecting and interpreting diagnostic tests. Biochem Med (Zagreb) 17, 151–61.
16. Irwig L, Bossuyt P, Glasziou P et al. (2002) Designing studies to ensure that estimates of test accuracy are transferable. BMJ 324, 669–71.
17. Felson DT, Smolen JS, Wells G et al. (2011) American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Arthritis Rheum 63, 573–86.